J Korean Med Sci.
2019 Apr;34(15):e127. 10.3346/jkms.2019.34.e127.
Prediction of Patients Who Can Benefit from Oral Intestinal Sorbent AST-120
- Affiliations
-
- 1Department of Internal Medicine, National Medical Center, Seoul, Korea. reginaprayer@gmail.com
- KMID: 2443210
- DOI: http://doi.org/10.3346/jkms.2019.34.e127
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Effects of Oral Adsorbent AST-120 (Kremezin(R)) on the Progression of Chronic Kidney Disease
- AST-120 Improves Microvascular Endothelial Dysfunction in End-Stage Renal Disease Patients Receiving Hemodialysis
- Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial
- Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea
- Predictive Factors for Efficacy of AST-120 Treatment in Diabetic Nephropathy: a Prospective Single-Arm, Open-Label, Multi-Center Study
